Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the most prevalent and lethal causes of cancer-
related death worldwide. The treatment of HCC remains challenging and is largely …
related death worldwide. The treatment of HCC remains challenging and is largely …
Management of hepatocellular carcinoma in Japan: JSH consensus statements and recommendations 2021 update
M Kudo, Y Kawamura, K Hasegawa, R Tateishi… - Liver cancer, 2021 - karger.com
Abstract The Clinical Practice Manual for Hepatocellular Carcinoma was published based
on evidence confirmed by the Evidence-based Clinical Practice Guidelines for …
on evidence confirmed by the Evidence-based Clinical Practice Guidelines for …
Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases
This guidance provides a data-supported approach to the diagnosis, staging, and treatment
of patients diagnosed with hepatocellular carcinoma (HCC). A guidance document is …
of patients diagnosed with hepatocellular carcinoma (HCC). A guidance document is …
Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
M Omata, AL Cheng, N Kokudo, M Kudo, JM Lee… - Hepatology …, 2017 - Springer
There is great geographical variation in the distribution of hepatocellular carcinoma (HCC),
with the majority of all cases worldwide found in the Asia–Pacific region, where HCC is one …
with the majority of all cases worldwide found in the Asia–Pacific region, where HCC is one …
Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches
G Sapisochin, J Bruix - Nature reviews Gastroenterology & hepatology, 2017 - nature.com
Liver transplantation for hepatocellular carcinoma (HCC) is the best treatment option for
patients with early-stage tumours and accounts for∼ 20–40% of all liver transplantations …
patients with early-stage tumours and accounts for∼ 20–40% of all liver transplantations …
Current status and perspective biomarkers in AFP negative HCC: towards screening for and diagnosing hepatocellular carcinoma at an earlier stage
P Luo, S Wu, Y Yu, X Ming, S Li, X Zuo, J Tu - Pathology & Oncology …, 2020 - Springer
Hepatocellular carcinoma (HCC) is one of the most malignant cancer with high morbidity
and mortality which lead to a serious burden to society. AFP (alpha-fetoprotein) is the most …
and mortality which lead to a serious burden to society. AFP (alpha-fetoprotein) is the most …
Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma
M Omata, LA Lesmana, R Tateishi, PJ Chen… - Hepatology …, 2010 - Springer
Abstract Introduction The Asian Pacific Association for the Study of the Liver (APASL)
convened an international working party on the management of hepatocellular carcinoma …
convened an international working party on the management of hepatocellular carcinoma …
[HTML][HTML] Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion
N Poté, F Cauchy, M Albuquerque, H Voitot… - Journal of …, 2015 - Elsevier
Background & Aims Prothrombin induced by vitamin K absence-II (PIVKA-II) is a diagnostic
and surveillance marker for HCC mainly used in Asia, and has also been shown to be a …
and surveillance marker for HCC mainly used in Asia, and has also been shown to be a …
Des-γ-carboxy prothrombin and α-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma
AS Lok, RK Sterling, JE Everhart, EC Wright, JC Hoefs… - Gastroenterology, 2010 - Elsevier
BACKGROUND & AIMS: The outcome of patients with hepatocellular carcinoma (HCC)
remains poor because of late diagnosis. The aim of this study was to compare the accuracy …
remains poor because of late diagnosis. The aim of this study was to compare the accuracy …
[HTML][HTML] Guide for diagnosis and treatment of hepatocellular carcinoma
MH Attwa, SA El-Etreby - World journal of hepatology, 2015 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is ranked as the 5 th common type of cancer worldwide
and is considered as the 3 rd common reason for cancer-related deaths. HCC often occurs …
and is considered as the 3 rd common reason for cancer-related deaths. HCC often occurs …